Sign in

CIK 0000863894

  • Non-accelerated filer
  • Smaller reporting company
Ticker
VERU
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Sep 30
Incorporated
WI
Entity type
Operating
EIN
391144397
Phone
+1 312-595-9123
Business address
2916 N. MIAMI AVENUE, SUITE 1000, MIAMI, FL, 33127
Former names
FEMALE HEALTH CO
  1. 4 Open-market buy Chief Executive Officer bought 10,000 shares at $1.48 ($14,838)
  2. 4 Open-market buy Director bought 25,000 shares at an average $1.47 ($36,679)
  3. 4 Grant or award Exec VP of Sales & Marketing acquired 11,178 shares (grant or award)
  4. 4 Grant or award Exec. VP of Global Operations acquired 11,178 shares (grant or award)
  5. 4 Grant or award Exec VP and CFO acquired 11,178 shares (grant or award)
  6. 4 Grant or award Exec. VP of Global Operations acquired 9,333 shares (grant or award)
  7. 4 Grant or award Chief Executive Officer acquired 67,000 shares (grant or award)
  8. 4 Grant or award Director acquired 50,000 shares (grant or award)
  9. 4 Grant or award Director acquired 50,000 shares (grant or award)
  10. 4 Grant or award Executive VP/Sales & Marketing acquired 12,000 shares (grant or award)
  11. 3 Insider Initial Statement of Ownership
  12. 4 Open-market buy President and CEO bought 1,000 shares at $3.86 ($3,860)
  13. 4 Gift Director gave 3,730 shares (gift)
  14. 4 Gift Director gave 31,000 shares (gift)
  15. 4 Gift Director gave 17,500 shares (gift)
  16. 3 Insider Initial Statement of Ownership
  17. 4 Shares withheld for taxes Director gave up 13,037 shares (to pay taxes)
  18. 4 Gift Director gave 7,000 shares (gift)
  19. 4 Open-market buy Director bought 5,000 shares at $4.05 ($20,250)
  20. 4 Open-market buy Director bought 2,500 shares at $3.90 ($9,750)

Page 15 of 30 · 594 filings